A

Amgen

Makes biotech medicines for serious illnesses

Director: Targeted Protein Degradation

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeThousand Oaks, CA, USAIn-person

About the Job

Requirements

  • A doctorate degree and 4 years of scientific experience, a master's degree and 8 years of scientific experience, or a bachelor's degree and 10 years of scientific experience is required.
  • At least 4 years of experience directly managing people and/or leadership experience leading teams, projects, or programs, or directing resource allocation, is required; this experience may run concurrently with the required technical experience.
  • A PhD in Chemical Biology, Biochemistry, Molecular Biology, Pharmacology, Medicinal Chemistry, or a related scientific discipline is preferred.
  • Recognized scientific leadership and significant contributions to targeted protein degradation, molecular glues, induced proximity biology, or adjacent fields are preferred.
  • Deep understanding of degrader mechanisms, E3 ligase biology, chemical proteomics, structural biology, and translational pharmacology is preferred.
  • Experience establishing scientific strategies, building research capabilities, and driving organizational transformation is preferred.
  • Strong understanding of emerging computational and artificial intelligence-enabled approaches in drug discovery is preferred.
  • Demonstrated success developing strategic external collaborations and evaluating innovative technologies is preferred.
  • Exceptional communication, influencing, and leadership skills, including the ability to engage scientific teams and executive leadership, are preferred.

Responsibilities

  • Define and execute a long-term scientific vision for targeted protein degradation and proximity-based therapeutics, expanding platform applications into new biological spaces, therapeutic opportunities, and modalities.
  • Establish a scientific strategy to identify where degradation and proximity-based mechanisms can address high-value biological targets and disease pathways beyond conventional therapeutic approaches.
  • Drive innovation across molecular glues, heterobifunctional degraders, tissue-selective degraders, event-driven pharmacology, and emerging induced proximity modalities.
  • Develop frameworks to identify, evaluate, and prioritize biological opportunities enabled by targeted protein degradation and proximity biology.
  • Anticipate scientific, technological, and competitive trends and translate them into platform strategies and capability investments.
  • Advise Research leadership on platform investments, capability development, and long-range innovation strategy.
  • Foster scientific ambition, rigor, and innovation.
  • Define and build capabilities in chemical biology, proteomics, functional genomics, structural biology, computational biology, machine learning, and translational sciences.
  • Integrate artificial intelligence and data-driven approaches into target identification, ligand discovery, degrader design, mechanism elucidation, and prediction of therapeutic outcomes.
  • Develop and adopt experimental and computational technologies to accelerate discovery and deepen mechanistic understanding of induced proximity biology.
  • Establish scalable scientific workflows and decision-making frameworks to translate emerging concepts into drug discovery opportunities.
  • Identify capability gaps and build internal expertise, external partnerships, and enabling technologies.
  • Build, mentor, and develop a high-performing multidisciplinary team of scientists across chemical biology, protein degradation, chemistry, proteomics, and drug discovery.
  • Foster collaboration, accountability, inclusion, and scientific excellence.
  • Attract, develop, and retain scientific talent while creating growth and leadership-development opportunities.
  • Create an innovative environment where ideas are encouraged, evaluated, and translated into scientific outcomes.
  • Partner with Therapeutic Areas, Medicinal Chemistry, Research Informatics, Translational Sciences, Pharmacology, and Development organizations to maximize the impact of targeted protein degradation across the research portfolio.
  • Align functions to execute and translate platform innovations into therapeutic opportunities.
  • Identify and evaluate scientific advances, enabling technologies, and partnership opportunities that strengthen platform differentiation and long-term impact.
  • Cultivate an external network of scientific leaders and innovators to maintain early visibility into advances across chemistry, biology, computation, and drug discovery.
  • Represent the Induced Proximity Platform in scientific, strategic, and executive forums and communicate a vision for induced proximity biology and future medicines.

Desired Qualifications

  • A discretionary annual bonus program or, for field sales representatives, a sales-based incentive plan is offered based on eligibility.
  • Stock-based long-term incentives are offered based on eligibility.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs